https://research.ouhsc.edu/news Parent Page: News id: -1 Active Page: News id: 26727

OU Health Campus Office of the Vice President for Research

Research News

University of Oklahoma Launches Project 200, a Generational Investment in Oklahoma’s Future

Together for Oklahoma: Research driving health, prosperity and security The University of Oklahoma today announced Project 200, a generational investment in research, talent and infrastructure designed to move Oklahoma forward by strengthening the health of its people, growing the...

Weekly Research Newsletters

University of Oklahoma Launches Project 200, a Generational Investment in Oklahoma’s Future

The University of Oklahoma today announced Project 200, a generational investment in research, talent and infrastructure designed to move Oklahoma forward by strengthening the health of its...
Read More >

Blocking Stress Signals Could Limit Harmful Inflammation After Heart Attack

After a heart attack, the body rapidly floods the injured heart with neutrophils — white blood cells that help repair damage but can also make it worse when too many arrive too quickly. New...
Read More >

The Lancet Paper Calls for Earlier Diagnosis as Leprosy Persists Globally

Although often considered a disease of the past, leprosy remains a global health issue, causing preventable disability due to delayed diagnosis and gaps in care. In a paper published in The...
Read More >

Genetic Study Finds New Pathways Involved in Cardiometabolic Disease

A study published today in PLOS Medicine has identified two new genetic pathways that contribute to cardiometabolic disease, which includes heart disease, obesity and diabetes. The research, led...
Read More >

Jennings Accepted Into National Leadership Program

University of Oklahoma College of Medicine Associate Professor Lee Jennings, M.D., chief of the Division of Geriatrics and Palliative Medicine in the Department of Internal Medicine, has been...
Read More >

Experimental Drug Offers Hope for Patients with Advanced Pancreatic Cancer

Results from a Phase 3 clinical trial offer new hope for patients with advanced pancreatic cancer, showing the experimental drug daraxonrasib significantly extended survival compared with...
Read More >